While screening for ovarian cancer is not effective in the general population [49], some experts recommend that women with mutations in BRCA1 and 2, as well as women with strong family histories of breast or ovarian cancer have some form of screening with CA125, and transvaginal ultrasound, as often as every 3 months [50]. This evidence concerns the gene BRCA1 and ovarian carcinoma.